{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:10:26Z","timestamp":1789168226645,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA15135"],"award-info":[{"award-number":["CA15135"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA18133"],"award-info":[{"award-number":["CA18133"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA18240"],"award-info":[{"award-number":["CA18240"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["INST 208\/664-1 FUGG"],"award-info":[{"award-number":["INST 208\/664-1 FUGG"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CA15135"],"award-info":[{"award-number":["CA15135"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CA18133"],"award-info":[{"award-number":["CA18133"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CA18240"],"award-info":[{"award-number":["CA18240"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 208\/664-1 FUGG"],"award-info":[{"award-number":["INST 208\/664-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["CA15135"],"award-info":[{"award-number":["CA15135"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["CA18133"],"award-info":[{"award-number":["CA18133"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["CA18240"],"award-info":[{"award-number":["CA18240"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["INST 208\/664-1 FUGG"],"award-info":[{"award-number":["INST 208\/664-1 FUGG"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biopha.2021.111517","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T07:59:37Z","timestamp":1616572777000},"page":"111517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The histamine H3R and dopamine D2R\/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf\/J mice by multiple actions"],"prefix":"10.1016","volume":"138","author":[{"given":"Karthikkumar","family":"Venkatachalam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Al","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrilla","family":"Jayaprakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"St\u00f6lting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassem","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116363","article-title":"Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid","volume":"10","author":"Baronio","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111517_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fnins.2018.00304","article-title":"Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder","volume":"12","author":"Eissa","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2021.111517_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108775","article-title":"The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice","volume":"312","author":"Eissa","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"11","key":"10.1016\/j.biopha.2021.111517_bib4","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.3390\/ijms21113996","article-title":"The dual-active histamine h3 receptor antagonist and acetylcholine esterase inhibitor E100 alleviates autistic-like behaviors and oxidative stress in valproic acid induced autism in mice","volume":"21","author":"Eissa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib5","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1038\/s41598-018-31385-7","article-title":"The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism","volume":"8","author":"Eissa","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111517_bib6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3389\/fphar.2020.00886","article-title":"Role of neuroinflammation in autism spectrum disorder and the emergence of brain histaminergic system. Lessons also for BPSD?","volume":"11","author":"Eissa","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111517_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuropharm.2012.07.013","article-title":"AMPAKINE enhancement of social interaction in the BTBR mouse model of autism","volume":"64","author":"Silverman","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib8","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1542\/peds.2009-0958","article-title":"Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model","volume":"125","author":"Dawson","year":"2010","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/15374410701817808","article-title":"Evidence-based comprehensive treatments for early autism","volume":"37","author":"Rogers","year":"2008","journal-title":"J. Clin. Child Adolesc. Psychol."},{"key":"10.1016\/j.biopha.2021.111517_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108775","article-title":"The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice","volume":"312","author":"Eissa","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.biopha.2021.111517_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111517_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbr.2015.10.022","article-title":"The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats","volume":"297","author":"Khan","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"26","key":"10.1016\/j.biopha.2021.111517_bib13","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.2174\/1381612821666150605105325","article-title":"Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?","volume":"21","author":"Ellenbroek","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.biopha.2021.111517_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ajmg.a.36847","article-title":"Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility","volume":"167A","author":"Bacchelli","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"issue":"6","key":"10.1016\/j.biopha.2021.111517_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/14656566.2017.1308483","article-title":"Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline","volume":"18","author":"Hellings","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"issue":"5","key":"10.1016\/j.biopha.2021.111517_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000478725","article-title":"A dopamine hypothesis of autism spectrum disorder","volume":"39","author":"Pav\u0103l","year":"2017","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.biopha.2021.111517_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.physbeh.2016.08.022","article-title":"The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats","volume":"165","author":"Sadek","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2021.111517_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbr.2016.06.051","article-title":"Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases","volume":"312","author":"Sadek","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2021.111517_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuropharm.2015.11.005","article-title":"Cherry-picked ligands at histamine receptor subtypes","volume":"106","author":"Sadek","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.biopha.2021.111517_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-publhealth-031816-044318","article-title":"The changing epidemiology of autism spectrum disorders","volume":"38","author":"Lyall","year":"2017","journal-title":"Annu. Rev. Public Health"},{"issue":"7","key":"10.1016\/j.biopha.2021.111517_bib22","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1007\/s12035-017-0770-5","article-title":"Excessive D1 dopamine receptor activation in the dorsal striatum promotes autistic-like behaviors","volume":"55","author":"Lee","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"5911","key":"10.1016\/j.biopha.2021.111517_bib23","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor","volume":"302","author":"Arrang","year":"1983","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2021.111517_bib24","first-page":"1101","article-title":"Cloning and functional expression of the human histamine H3 receptor","volume":"55","author":"Lovenberg","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111517_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/pr.114.010249","article-title":"International Union of Basic and Clinical Pharmacology. XCVIII. Histamine receptors","volume":"67","author":"Panula","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.05.001","article-title":"Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system","volume":"103","author":"Witkin","year":"2004","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2021.111517_bib27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bmcl.2008.09.012","article-title":"Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics","volume":"19","author":"Von Coburg","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2021.111517_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pbb.2012.04.004","article-title":"SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents","volume":"102","author":"Griebel","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116363","article-title":"Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid","volume":"10","author":"Baronio","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111517_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pnpbp.2018.09.012","article-title":"Increased oxidative stress in the cerebellum and peripheral immune cells leads to exaggerated autism-like repetitive behavior due to deficiency of antioxidant response in BTBR T+tf\/J mice","volume":"89","author":"Nadeem","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2021.111517_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107323","article-title":"Aggravation of autism-like behavior in BTBR T+tf\/J mice by environmental pollutant, di-(2-ethylhexyl) phthalate: role of nuclear factor erythroid 2-related factor 2 and oxidative enzymes in innate immune cells and cerebellum","volume":"91","author":"Nadeem","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.111517_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1476-511X-11-160","article-title":"Lipid mediators in plasma of autism spectrum disorders","volume":"11","author":"El-Ansary","year":"2012","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.biopha.2021.111517_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2217\/bmm.13.158","article-title":"Metabolic pathology of autism in relation to redox metabolism","volume":"8","author":"Frye","year":"2014","journal-title":"Biomark. Med."},{"issue":"8","key":"10.1016\/j.biopha.2021.111517_bib34","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1096\/fj.08-128926","article-title":"Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism","volume":"23","author":"James","year":"2009","journal-title":"FASEB J."},{"issue":"21","key":"10.1016\/j.biopha.2021.111517_bib35","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.lfs.2004.04.038","article-title":"Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins","volume":"75","author":"Chauhan","year":"2004","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111517_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12311-009-0105-9","article-title":"Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism","volume":"8","author":"Sajdel-Sulkowska","year":"2009","journal-title":"Cerebellum"},{"key":"10.1016\/j.biopha.2021.111517_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/532640","article-title":"The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels","volume":"2009","author":"Adams","year":"2009","journal-title":"J. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111517_bib38","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s11064-012-0775-4","article-title":"Brain region-specific glutathione redox imbalance in autism","volume":"37","author":"Chauhan","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2021.111517_bib39","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.freeradbiomed.2013.07.021","article-title":"Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes","volume":"65","author":"Gu","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"17","key":"10.1016\/j.biopha.2021.111517_bib40","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O\u2019Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2021.111517_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0891-5849(93)90027-R","article-title":"Oxygen-radical absorbance capacity assay for antioxidants","volume":"14","author":"Cao","year":"1993","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111517_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2015.10.023","article-title":"Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats","volume":"106","author":"Sadek","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.0021-9630.2003.00317.x","article-title":"Autism and pervasive developmental disorders","volume":"45","author":"Volkmar","year":"2004","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1096-8628(20010108)105:1<36::AID-AJMG1053>3.0.CO;2-4","article-title":"Quantifying the phenotype in autism spectrum disorders","volume":"105","author":"Lord","year":"2001","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1469-7610.2006.01594.x","article-title":"Social\u2010cognition and the broad autism phenotype: identifying genetically meaningful phenotypes","volume":"48","author":"Losh","year":"2007","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.biopha.2021.111517_bib46","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR\u00ae","author":"Frances","year":"2000"},{"issue":"4","key":"10.1016\/j.biopha.2021.111517_bib47","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/npp.2009.201","article-title":"Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP","volume":"35","author":"Silverman","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2021.111517_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbi.2014.06.006","article-title":"Inflammatory profiles in the BTBR mouse: how relevant are they to autism spectrum disorders?","volume":"43","author":"Careaga","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2021.111517_bib49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fnins.2013.00158","article-title":"Inflammatory macrophage phenotype in BTBR T+tf\/J mice","volume":"7","author":"Onore","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2021.111517_bib50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2017.05.018","article-title":"IL-17A causes depression-like symptoms via NFkappaB and p38MAPK signaling pathways in mice: implications for psoriasis associated depression","volume":"97","author":"Nadeem","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2021.111517_bib51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbi.2016.12.024","article-title":"Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism","volume":"61","author":"Nadeem","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.biopha.2021.111517_bib52","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s11481-013-9462-8","article-title":"Evidence for a dysregulated immune system in the etiology of psychiatric disorders","volume":"8","author":"Gibney","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111517_bib53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","article-title":"Autism-like behavioral phenotypes in BTBR T+tf\/J mice","volume":"7","author":"McFarlane","year":"2008","journal-title":"Genes Brain Behav."},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib54","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1038\/s41598-018-31385-7","article-title":"The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism","volume":"8","author":"Eissa","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111517_bib55","article-title":"Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice","volume":"82","author":"Angoa-P\u00e9rez","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2021.111517_bib56","first-page":"627","article-title":"Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H3 receptor antagonist ST-1283","volume":"8","author":"Bahi","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.biopha.2021.111517_bib57","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","volume":"96","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"9","key":"10.1016\/j.biopha.2021.111517_bib58","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3390\/biom10091251","article-title":"Simultaneous blockade of histamine H3 receptors and inhibition of acetylcholine esterase alleviate autistic-like behaviors in BTBR T+ tf\/J mouse model of autism","volume":"10","author":"Eissa","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2021.111517_bib59","unstructured":"K.R. Bailey, J.N. Crawley, Anxiety-related behaviors in mice, in: J.J. Buccafusco (Eds.), Methods of Behavior Analysis in Neuroscience, Boca Raton, FL, 2009."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.111517_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111517_bib61","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"issue":"4","key":"10.1016\/j.biopha.2021.111517_bib62","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/npp.2013.274","article-title":"Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism","volume":"39","author":"Karvat","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.biopha.2021.111517_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.87","article-title":"Altered expression of histamine signaling genes in autism spectrum disorder","volume":"7","author":"Wright","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2021.111517_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.87","article-title":"Altered expression of histamine signaling genes in autism spectrum disorder","volume":"7","author":"Wright","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12991-014-0034-y","article-title":"Histaminergic system in brain disorders: lessons from the translational approach and future perspectives","volume":"13","author":"Baronio","year":"2014","journal-title":"Ann. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2021.111517_bib66","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/WCO.0b013e32835ee548","article-title":"Sex differences in autism spectrum disorders","volume":"26","author":"Werling","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.biopha.2021.111517_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.69","article-title":"Dysfunctional dopaminergic neurotransmission in asocial BTBR mice","volume":"4","author":"Squillace","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2021.111517_bib68","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0278-5846(98)00051-7","article-title":"Combination of open field and elevated plus-maze: a suitable test battery to assess strain as well as treatment differences in rat behavior","volume":"22","author":"Schmitt","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbr.2006.07.030","article-title":"Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains","volume":"176","author":"Moy","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111517_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062189","article-title":"The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex","volume":"8","author":"McTighe","year":"2013","journal-title":"PLoS One"},{"issue":"2\u20134","key":"10.1016\/j.biopha.2021.111517_bib71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/S1740925X12000142","article-title":"Evidence of microglial activation in autism and its possible role in brain underconnectivity","volume":"7","author":"Rodriguez","year":"2011","journal-title":"Neuron Glia Biol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib72","first-page":"67","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2021.111517_bib73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000492113","article-title":"Neuroimmune alterations in autism: a translational analysis focusing on the animal model of autism induced by prenatal exposure to valproic acid","volume":"25","author":"Deckmann","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.biopha.2021.111517_bib74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ntt.2012.07.006","article-title":"Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment","volume":"36","author":"Goines","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.biopha.2021.111517_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fpsyt.2011.00027","article-title":"Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation","volume":"2","author":"Young","year":"2011","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2021.111517_bib76","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.schres.2013.02.017","article-title":"RETRACTED: increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients","volume":"147","author":"Rao","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111517_bib77","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbr.2008.12.016","article-title":"Immune involvement in schizophrenia and autism: etiology, pathology and animal models","volume":"204","author":"Patterson","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111517_bib78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000398791","article-title":"Role of microglia in autism: recent advances","volume":"37","author":"Takano","year":"2015","journal-title":"Dev. Neurosci."},{"issue":"20","key":"10.1016\/j.biopha.2021.111517_bib79","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1007\/s00018-014-1670-8","article-title":"Microglia and inflammation: conspiracy, controversy or control?","volume":"71","author":"Fernandes","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2021.111517_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020912","article-title":"Aberrant immune responses in a mouse with behavioral disorders","volume":"6","author":"Heo","year":"2011","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111517_bib81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2013.02.019","article-title":"The maternal autoimmune environment affects the social behavior of offspring","volume":"258","author":"Zhang","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2021.111517_bib82","doi-asserted-by":"crossref","DOI":"10.1007\/164_2016_127","article-title":"Histidine Decarboxylase Knockout Mice as a Model of the Pathophysiology of Tourette Syndrome and Related Conditions","volume":"241","author":"Pittenger","year":"2017","journal-title":"Handb Exp Pharmacol"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:27:28Z","timestamp":1760099248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221003024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":82,"alternative-id":["S0753332221003024"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111517","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The histamine H3R and dopamine D2R\/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf\/J mice by multiple actions","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111517"}}